2m 2m 2m 2m 2m 2m 2m
MariMed (MRMD)
OTC
$0.08-$0.002 (-2.32%)
Price as of Jun 03, 2026- $31.1MMarket Cap
- 4.48%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
MariMed (MRMD)
$0.08-$0.002 (-2.32%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 159.8M +1.18% | 158.0M +6.30% | 148.6M +10.89% | 134.0M N/A | |
Cost of Revenue | 101.9M +7.20% | 95.1M +15.02% | 82.7M +18.02% | 70.1M +26.91% | |
Gross Profit | 57.9M -7.93% | 62.9M -4.63% | 65.9M +3.07% | 64.0M -3.48% | |
Sales and Marketing Expense | 4.0M -40.34% | 6.7M +11.49% | 6.0M +59.98% | 3.7M +129.89% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 8.1M +2.52% | 7.9M +42.55% | 5.5M +332.84% | 1.3M +85.71% | |
Total Operating Expenses | 60.7M +1.24% | 60.0M +16.34% | 51.5M +18.23% | 43.6M +10.63% | |
Operating Profit | -2.8M -196.84% | 2.9M -79.76% | 14.4M -29.38% | 20.4M -24.18% | |
Interest Income | 177,000 +55.26% | 114,000 -57.78% | 270,000 -71.85% | 959,000 +786.17% | |
Interest Expense | N/A N/A | N/A N/A | -9.2M +442.53% | -1.7M -28.14% | |
Interest Income and Expense and Net | 177,000 +55.26% | 114,000 +101.28% | -8.9M +1,114.58% | -734,000 -67.34% | |
Total Nonoperating Income and Expense | -8.0M +16.89% | -6.9M -67.21% | -21.0M +2,336.82% | -861,000 -71.75% | |
Income before Taxes | -10.9M +173.74% | -4.0M -39.84% | -6.6M -133.81% | 19.5M -18.09% | |
Income Taxes | 3.6M -55.95% | 8.2M -13.30% | 9.4M +59.67% | 5.9M -63.60% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -14.5M +19.07% | -12.2M -24.12% | -16.0M -219.03% | 13.5M +86.42% | |
Net Income from Continuing Operations Applicable to Common | -10.9M +173.74% | -4.0M -39.84% | -6.6M -133.81% | 19.5M -18.09% | |
Basic EPS and Net Income | -0.04 +33.33% | -0.03 -25.00% | -0.04 -200.00% | 0.04 +100.00% | |
Diluted EPS and Net Income | -0.04 +33.33% | -0.03 -25.00% | -0.04 -200.00% | 0.04 +100.00% | |
Basic Weighted Average Shares | 390.1M +2.90% | 379.2M +4.33% | 363.4M +7.61% | 337.7M +3.44% | |
Diluted Weighted Average Shares | 390.1M +2.90% | 379.2M +4.33% | 363.4M -4.44% | 380.3M +2.12% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8.9M +22.00% | 7.3M -50.28% | 14.6M +50.41% | 9.7M -67.20% | |
Short-Term Investments | N/A N/A | 0 -100.00% | 88,000 -28.46% | 123,000 -50.92% | |
Cash and Cash Equivalents and Short-Term Investments | 8.9M +22.00% | 7.3M -50.57% | 14.7M +49.42% | 9.9M -67.06% | |
Total Current Assets | 59.3M +10.80% | 53.5M +4.04% | 51.4M +16.50% | 44.1M -1.05% | |
Accumulated Depreciation | 27.1M +25.35% | 21.6M +45.11% | 14.9M +45.89% | 10.2M +47.03% | |
Property and Plant and Equipment and Net | 89.4M -5.08% | 94.2M +5.68% | 89.1M +24.37% | 71.6M +15.27% | |
Total Long-Term Assets | 931,000 -91.70% | 11.2M -10.51% | 12.5M +1,124.32% | 1.0M +945.42% | |
Total Assets | 202.6M -2.14% | 207.0M +5.54% | 196.1M +28.86% | 152.2M +23.54% | |
Income Taxes Payable | 27.0M +23.08% | 21.9M +51.88% | 14.4M +25.63% | 11.5M -37.10% | |
Total Short-Term Debt | 2.6M -50.20% | 5.1M +608.99% | 723,000 -80.84% | 3.8M +38,055.90% | |
Total Current Liabilities | 59.1M +21.34% | 48.7M +57.73% | 30.9M +16.50% | 26.5M -2.69% | |
Total Long-Term Debt | 129.6M -14.23% | 151.1M +17.77% | 128.3M +394.60% | 25.9M +5,686.44% | |
Total Long-Term Liabilities | 0 -100.00% | 100,000 0.00% | 100,000 0.00% | 100,000 -0.20% | |
Total Liabilities | 137.8M +7.59% | 128.1M +19.50% | 107.2M +87.54% | 57.2M +16.24% | |
Retained Earnings | -127.9M +14.10% | -112.1M +12.17% | -100.0M +19.10% | -83.9M -13.83% | |
Total Stockholders Equity | 50.0M -16.48% | 59.9M -14.36% | 69.9M +21.99% | 57.3M +57.88% | |
Total Shares Outstanding | 396.9M +4.05% | 381.5M +1.69% | 375.1M +9.85% | 341.5M +2.23% | |
Cash Flow | |||||
Cash from Operating Activities | 7.7M +13.41% | 6.8M -14.22% | 7.9M +8.19% | 7.3M -79.61% | |
Capital Expenditures | 1.2M -90.24% | 12.0M -40.59% | 20.1M +65.82% | 12.1M -32.08% | |
Cash from Investing Activities | -1.4M -91.95% | -17.1M -34.07% | -26.0M -0.99% | -26.2M +57.87% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -4.7M -257.89% | 3.0M -87.01% | 23.0M +2,368.81% | -1.0M -113.59% | |
Financials Ratio | |||||
Gross Margin | 36.22% -9.01% | 39.80% -10.28% | 44.36% -7.05% | 47.73% N/A | |
Operating Margin | -1.76% -195.71% | 1.84% -80.96% | 9.68% -36.31% | 15.20% N/A | |
Return on Assets | -7.07% +17.20% | -6.03% -34.43% | -9.20% -194.11% | 9.78% +35.14% | |
Return on Equity | -26.36% +40.64% | -18.74% -25.62% | -25.20% -187.58% | 28.78% -11.58% | |
Revenue Growth | 1.18% -81.30% | 6.30% -42.10% | 10.89% N/A | N/A N/A | |
Current Ratio | 1.00 -8.68% | 1.10 -34.04% | 1.67 0.00% | 1.67 +1.69% | |
Cash Ratio | 0.15 +0.53% | 0.15 -68.47% | 0.47 +29.08% | 0.37 -66.29% | |
Debt-to-Equity Ratio | 2.64 +1.28% | 2.61 +41.38% | 1.85 +255.95% | 0.52 +4,015.08% | |
Debt-to-Assets Ratio | 0.65 -13.55% | 0.75 +14.73% | 0.66 +237.04% | 0.20 +5,175.68% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow